Department of Chemistry & Biochemistry and the Biomolecular Sciences Institute, Florida International University, Miami, FL 33199, USA.
Department of Cellular Biology & Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
J Inorg Biochem. 2024 Jan;250:112402. doi: 10.1016/j.jinorgbio.2023.112402. Epub 2023 Oct 14.
Two indium(III) complexes of formula mer-[InCl(4-Me-pzH)] and trans-[InCl(4-Me-pzH)]Cl·(4-Me-pzH)·(HO) were isolated from the same reaction mixture and crystallographically characterized. The two complexes exist in dynamic equilibrium and their dynamic behavior was probed by variable temperature H NMR spectroscopy in the 202 to 296 K range. Powder X-ray diffraction of the batch confirmed existence of both complexes in a 1:2 ratio. Antibacterial properties of both new complexes, in addition to seven other previously published indium(III) complexes, were investigated against three Gram-positive and four Gram-negative pathogenic bacterial strains. The results showed potential for the development of indium(III)-based antipseudomonal and antituberculosis drugs, with mer-[InCl(4-Ph-pzH)] being especially effective.
从同一反应混合物中分离出并通过晶体学进行了表征的式 mer-[InCl(4-Me-pzH)] 和 trans-[InCl(4-Me-pzH)]Cl·(4-Me-pzH)·(HO) 的两个铟(III)配合物。这两个配合物处于动态平衡中,其动态行为通过在 202 至 296 K 范围内的变温 H NMR 光谱进行了探测。批处理的粉末 X 射线衍射证实了这两种配合物以 1:2 的比例存在。除了之前发表的七个其他铟(III)配合物之外,还研究了这两个新配合物以及另外七个配合物对三种革兰氏阳性和四种革兰氏阴性病原菌的抗菌性能。结果表明,基于铟(III)的抗假单胞菌和抗结核药物具有开发潜力,其中 mer-[InCl(4-Ph-pzH)] 尤为有效。